Stock DRREDDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01023

Delayed Bombay S.E.
Other stock markets
 04:02:41 2024-05-07 EDT 		5-day change 1st Jan Change
6,225 INR -1.20% Intraday chart for Dr. Reddy's Laboratories Limited +0.33% +7.37%
05-06 Indian shares set to open higher on Fed rate-cut hopes RE
05-03 Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Indian shares set to open higher on Fed rate-cut hopes
RE
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher
MT
Dr. Reddy's Laboratories Launches Generic Doxycycline Capsules in US
MT
Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
BU
Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg in the U.S
CI
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%
MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading
MT
Nestle India Reports Rise in Quarterly Profit, Announces JV With Dr. Reddy's Laboratories
DJ
Banking Stocks Lift Indian Equities Higher
MT
Dr. Reddy's Laboratories Names CEO-North America
MT
Dr. Reddy's Laboratories Limited Announces Executive Changes
CI
Dr. Reddy's Laboratories Limited and Nestle India Limited Enter into Joint Venture Agreement for Investment in Dr. Reddy's Nutraceuticals Limited
CI
Genentech And Dr. Reddy's Settle BPCIA Rituximab Litigation
AQ
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Oral Solution Powder in US
MT
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Powder Over Potency Concerns
MT
Dr Reddy Laboratories : . Reddy’s issues voluntary nationwide recall of Sapropterin Dihyochloride Powder for Oral Solution 100 mg due to Sub-potency - Form 6-K
PU
Dr. Reddy's Laboratories Limited Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 Mg Due to Sub-Potency
CI
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. News Dr. Reddy's Laboratories Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW